UMOD Gene Medullary Cystic Kidney Disease Type 2 Genetic Test
Test Name: UMOD Gene Medullary cystic kidney disease type 2 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Hepatology Nephrology Endocrinology Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for UMOD Gene Medullary cystic kidney disease type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with UMOD Gene Medullary cystic kidney disease type 2 NGS Genetic DNA Test gene UMOD
Test Details
The UMOD gene Medullary cystic kidney disease type 2 (MCKD2) NGS Genetic Test is a genetic test that analyzes the UMOD gene for mutations that are associated with Medullary Cystic Kidney Disease type 2.
Medullary Cystic Kidney Disease (MCKD) is a rare genetic disorder that affects the kidneys, causing the formation of cysts in the medulla, or inner part of the kidney. MCKD is typically inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the mutation to each of their children.
The UMOD gene provides instructions for making the uromodulin protein, which is found in the kidneys and plays a role in regulating the balance of salt and water in the body. Mutations in the UMOD gene can disrupt the normal function of uromodulin, leading to the development of cysts in the kidneys and the progression of MCKD2.
The UMOD gene Medullary cystic kidney disease type 2 NGS Genetic Test uses Next-Generation Sequencing (NGS) technology to analyze the UMOD gene for mutations. NGS allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of genetic variations that may be contributing to the development of MCKD2.
This genetic test can be used to confirm a diagnosis of MCKD2 in individuals with suspected symptoms or a family history of the condition. It can also be used for carrier testing in individuals who have a family history of MCKD2 but do not show any symptoms themselves.
The results of the UMOD gene Medullary cystic kidney disease type 2 NGS Genetic Test can help guide treatment decisions, provide information on disease prognosis, and inform family planning decisions for individuals at risk of passing on the condition.
It is typically performed by a healthcare professional, such as a genetic counselor or a geneticist, who can interpret the results and provide appropriate counseling and recommendations based on the findings.
| Test Name | UMOD Gene Medullary cystic kidney disease type 2 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hepatology Nephrology Endocrinology Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for UMOD Gene Medullary cystic kidney disease type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with UMOD Gene Medullary cystic kidney disease type 2 NGS Genetic DNA Test gene UMOD |
| Test Details |
UMOD gene Medullary cystic kidney disease type 2 (MCKD2) NGS Genetic Test is a genetic test that analyzes the UMOD gene for mutations that are associated with Medullary Cystic Kidney Disease type 2. Medullary Cystic Kidney Disease (MCKD) is a rare genetic disorder that affects the kidneys, causing the formation of cysts in the medulla, or inner part of the kidney. MCKD is typically inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the mutation to each of their children. The UMOD gene provides instructions for making the uromodulin protein, which is found in the kidneys and plays a role in regulating the balance of salt and water in the body. Mutations in the UMOD gene can disrupt the normal function of uromodulin, leading to the development of cysts in the kidneys and the progression of MCKD2. The UMOD gene Medullary cystic kidney disease type 2 NGS Genetic Test uses Next-Generation Sequencing (NGS) technology to analyze the UMOD gene for mutations. NGS allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of genetic variations that may be contributing to the development of MCKD2. This genetic test can be used to confirm a diagnosis of MCKD2 in individuals with suspected symptoms or a family history of the condition. It can also be used for carrier testing in individuals who have a family history of MCKD2 but do not show any symptoms themselves. The results of the UMOD gene Medullary cystic kidney disease type 2 NGS Genetic Test can help guide treatment decisions, provide information on disease prognosis, and inform family planning decisions for individuals at risk of passing on the condition. It is typically performed by a healthcare professional, such as a genetic counselor or a geneticist, who can interpret the results and provide appropriate counseling and recommendations based on the findings. |
